Insurer Positive Coverage Decisions Announced KIRKLAND, Wash.–(BUSINESS WIRE)–Kestra Medical Technologies announced today that the ASSURE® Wearable Cardioverter Defibrillator (WCD) system is now available in-network to over 100 million insurance plan members across the U.S. The company reached this covered-lives milestone for the ASSURE WCD system less than one year from when the first […]
Rhythm
Catheter Precision’s VIVO™ Systems Used in More Than 20 Procedures at NYU Langone Hospital
MT. OLIVE, N.J. & CARLSBAD, Calif.–(BUSINESS WIRE)–Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces the completion of more than 20 procedures at NYU Langone Hospital utilizing the VIVO System that enables physicians to identify the origin of arrhythmias pre-procedure. On September 12, 2022 privately […]
IDTechEx Discusses Three Applications for Electronic Skin Patches
BOSTON, Nov. 28, 2022 /PRNewswire/ — The world of healthcare is undergoing significant change. The stress test of the pandemic, a growing global population, and increasing chronic disease prevalence is pushing care to be more efficient and robust. Technology is facilitating this transformation, and one significant form of wearable technology that is increasingly […]
New AF and Congenital Heart Disease Data on Vektor Medical’s vMap® Presented at the 15th Asia Pacific Heart Rhythm Society Scientific Session
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s first technology to rapidly map cardiac arrhythmias using only 12-lead ECG data, today announced it presented new data on its vMap® technology that demonstrated potential utility in patients with adult congenital heart disease (ACHD) and refractory atrial fibrillation (AF) at the recent 15th Annual […]
Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Has No Clinically Significant Difference in Accuracy or Bias Between Black and White People
IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced the publication of a peer-reviewed study regarding Masimo SET® pulse oximetry performance in varying skin pigmentation in the Journal of Clinical Monitoring and Computing. The retrospective trial, “Racial effects on Masimo pulse oximetry: a laboratory study,” by Drs. Steven J. Barker and Wilson C. Wilson, found that there was […]
AliveCor’s KardiaMobile Card Honored by the 2022 Fierce Life Sciences Innovation Awards and the 2023 CES® Innovation Awards
KardiaMobile Card recognized for its impact in improving personal cardiac monitoring MOUNTAIN VIEW, Calif., Nov. 17, 2022 /PRNewswire/ — AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced that KardiaMobile Card, the world’s first credit-card-sized, FDA-cleared personal ECG device, has been named a 2022 Fierce Life Sciences Innovation Awards winner in the Medical […]
CONNEQT Pulse Selected as CES 2023 Innovation Award Honoree
World’s first at-home, customizable blood pressure monitor recognized as part of the distinguished Consumer Technology Association award IRVINE, Calif., Nov. 17, 2022 /PRNewswire/ — CONNEQT, a subsidiary of global health technology company CardieX Limited focused on cardiovascular disease, today announces its new upcoming arterial health monitor, the CONNEQT Pulse (Pulse), has been selected as a Consumer […]
New HeartBeam Patent for 12-Lead Electrocardiogram (ECG) Smartwatch-based Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias
Patent Opens Pathway to Disruptive Ischemia and Arrhythmia Detection Product in Multi-billion Dollar Wearables Device Market SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection anytime, anywhere, announced today that its patent for a […]
Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension
Successfully Met Primary and Secondary Endpoints, with Mean Placebo-Adjusted Reduction in Systolic Blood Pressure of 9.7 mmHg in Uncontrolled and Resistant Hypertensive Subjects at 50 mg Once Daily (p=0.01 vs. placebo) Subjects Using a Thiazide Diuretic (Approximately Half of the Study Population) Showed a Mean Placebo-Adjusted Reduction in Systolic Blood […]
Vivalink Expands Biometrics Data Platform with a Portfolio of Remote Data Capture Devices and Wearable Technology
The first real-world biometrics data platform for continuous and episodic remote patient monitoring now supports Roche, OMRON, Garmin, and other wearable medical devices to power virtual healthcare applications. CAMPBELL, Calif., Nov. 16, 2022 /PRNewswire/ — Vivalink, a leading provider of digital healthcare solutions, announces physiological data from a wide range of the world’s leading […]


